Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295432
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-02-07
Brief Title:
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations WU-KONG21
Sponsor:
Dizal Pharmaceuticals
Organization:
Dizal Pharmaceuticals
Organization Data
Organization:
Dizal Pharmaceuticals
Class:
INDUSTRY
Study ID:
DZ2022E0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dizal Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None